

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of B cell apoptotic process (GO:0002903) | 5.96982374 |
| 2 | behavioral response to nicotine (GO:0035095) | 5.95813782 |
| 3 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 5.88397811 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.59027364 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 5.59027364 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.49781426 |
| 7 | DNA deamination (GO:0045006) | 5.15189072 |
| 8 | regulation of immunoglobulin secretion (GO:0051023) | 4.95196735 |
| 9 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 4.86258102 |
| 10 | regulation of regulatory T cell differentiation (GO:0045589) | 4.60877005 |
| 11 | sequestering of actin monomers (GO:0042989) | 4.40408641 |
| 12 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.35438294 |
| 13 | regulation of B cell apoptotic process (GO:0002902) | 4.06371942 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 3.95174266 |
| 15 | positive regulation of prostaglandin secretion (GO:0032308) | 3.56124263 |
| 16 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.51350977 |
| 17 | protein neddylation (GO:0045116) | 3.50214823 |
| 18 | pseudouridine synthesis (GO:0001522) | 3.48625468 |
| 19 | peptidyl-histidine modification (GO:0018202) | 3.44503077 |
| 20 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.38472953 |
| 21 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.38472953 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.34796892 |
| 23 | respiratory electron transport chain (GO:0022904) | 3.33703504 |
| 24 | electron transport chain (GO:0022900) | 3.33087551 |
| 25 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.27843999 |
| 26 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.27843999 |
| 27 | isotype switching (GO:0045190) | 3.27843999 |
| 28 | cytidine catabolic process (GO:0006216) | 3.26899238 |
| 29 | cytidine deamination (GO:0009972) | 3.26899238 |
| 30 | cytidine metabolic process (GO:0046087) | 3.26899238 |
| 31 | protein complex biogenesis (GO:0070271) | 3.24902859 |
| 32 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.23631895 |
| 33 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.23631895 |
| 34 | NADH dehydrogenase complex assembly (GO:0010257) | 3.23631895 |
| 35 | regulation of memory T cell differentiation (GO:0043380) | 3.21853489 |
| 36 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.17497649 |
| 37 | myoblast migration (GO:0051451) | 3.13067078 |
| 38 | positive regulation of interleukin-17 production (GO:0032740) | 3.13066792 |
| 39 | regulation of prostaglandin secretion (GO:0032306) | 3.11305633 |
| 40 | negative regulation of telomere maintenance (GO:0032205) | 3.07740460 |
| 41 | ATP biosynthetic process (GO:0006754) | 3.04696070 |
| 42 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.04485262 |
| 43 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01994374 |
| 44 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.99859845 |
| 45 | L-fucose catabolic process (GO:0042355) | 2.95111027 |
| 46 | fucose catabolic process (GO:0019317) | 2.95111027 |
| 47 | L-fucose metabolic process (GO:0042354) | 2.95111027 |
| 48 | negative regulation of mast cell activation (GO:0033004) | 2.93624335 |
| 49 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.93232987 |
| 50 | interferon-gamma production (GO:0032609) | 2.91916606 |
| 51 | embryonic hemopoiesis (GO:0035162) | 2.90222448 |
| 52 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.85365519 |
| 53 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.85252340 |
| 54 | GTP biosynthetic process (GO:0006183) | 2.84545132 |
| 55 | positive regulation of immune response to tumor cell (GO:0002839) | 2.84164557 |
| 56 | regulation of immune response to tumor cell (GO:0002837) | 2.84164557 |
| 57 | regulation of response to tumor cell (GO:0002834) | 2.84164557 |
| 58 | positive regulation of response to tumor cell (GO:0002836) | 2.84164557 |
| 59 | tryptophan catabolic process (GO:0006569) | 2.83912866 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 2.83912866 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 2.83912866 |
| 62 | regulation of T cell migration (GO:2000404) | 2.83802092 |
| 63 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.82734863 |
| 64 | drug catabolic process (GO:0042737) | 2.82197715 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80749615 |
| 66 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.80316490 |
| 67 | regulation of hypersensitivity (GO:0002883) | 2.74566750 |
| 68 | termination of RNA polymerase III transcription (GO:0006386) | 2.74214711 |
| 69 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.74214711 |
| 70 | positive regulation of fatty acid transport (GO:2000193) | 2.73979747 |
| 71 | neuron fate determination (GO:0048664) | 2.72187711 |
| 72 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.71815474 |
| 73 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.67610006 |
| 74 | signal peptide processing (GO:0006465) | 2.66080778 |
| 75 | positive regulation of T cell migration (GO:2000406) | 2.63822337 |
| 76 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.63438516 |
| 77 | necroptotic process (GO:0070266) | 2.61852471 |
| 78 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.60763964 |
| 79 | negative T cell selection (GO:0043383) | 2.59368750 |
| 80 | retinal cone cell development (GO:0046549) | 2.57574640 |
| 81 | regulation of cell killing (GO:0031341) | 2.56292775 |
| 82 | negative regulation of macrophage differentiation (GO:0045650) | 2.55367636 |
| 83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.54998779 |
| 84 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.51063515 |
| 85 | hydrogen ion transmembrane transport (GO:1902600) | 2.50199308 |
| 86 | chaperone-mediated protein transport (GO:0072321) | 2.50059647 |
| 87 | synaptic transmission, cholinergic (GO:0007271) | 2.50001688 |
| 88 | negative thymic T cell selection (GO:0045060) | 2.49419722 |
| 89 | neural tube formation (GO:0001841) | 2.47595360 |
| 90 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.47471962 |
| 91 | positive regulation of DNA recombination (GO:0045911) | 2.44427175 |
| 92 | mast cell activation involved in immune response (GO:0002279) | 2.43770554 |
| 93 | mast cell degranulation (GO:0043303) | 2.43770554 |
| 94 | positive regulation of respiratory burst (GO:0060267) | 2.43593915 |
| 95 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.43123182 |
| 96 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.40792300 |
| 97 | positive regulation of isotype switching (GO:0045830) | 2.39890719 |
| 98 | kidney morphogenesis (GO:0060993) | 2.38888543 |
| 99 | positive regulation of activated T cell proliferation (GO:0042104) | 2.36501116 |
| 100 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.35837042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.28230237 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.47376662 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.32782186 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.07538199 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.81995039 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.81775435 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.73425302 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.70386796 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.51610288 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.42493949 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.42349834 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.26079046 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15583560 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10434179 |
| 15 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.03845469 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01676559 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.98586385 |
| 18 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.98292868 |
| 19 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.96082420 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.92846337 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.91706299 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.91169079 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79452743 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78027810 |
| 25 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.77758902 |
| 26 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.75498545 |
| 27 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.67180543 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60276174 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58512700 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55779250 |
| 31 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.51976750 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48606953 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48323431 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47440335 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46699270 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46401417 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44759275 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41132161 |
| 39 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.40432302 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37022141 |
| 41 | NCOR_22424771_ChIP-Seq_293T_Human | 1.32264891 |
| 42 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.31848669 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29368185 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28687518 |
| 45 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27851219 |
| 46 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.27285069 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27204567 |
| 48 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26402158 |
| 49 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.25511565 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24898287 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22338035 |
| 52 | AR_20517297_ChIP-Seq_VCAP_Human | 1.20106905 |
| 53 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18887228 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18382776 |
| 55 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.14959680 |
| 56 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.14197752 |
| 57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14138131 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14138131 |
| 59 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13878758 |
| 60 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.13664515 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12643348 |
| 62 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.11642177 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10756837 |
| 64 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.10230686 |
| 65 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.06435055 |
| 66 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06206888 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05486884 |
| 68 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.05064728 |
| 69 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.04619603 |
| 70 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03987570 |
| 71 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.03856603 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02347411 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02000565 |
| 74 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01258328 |
| 75 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.01044296 |
| 76 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99273720 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98765002 |
| 78 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97905690 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97546229 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97546229 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97202708 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97151549 |
| 83 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95998944 |
| 84 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94832200 |
| 85 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94651626 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.94105336 |
| 87 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93946886 |
| 88 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93463151 |
| 89 | ERA_21632823_ChIP-Seq_H3396_Human | 0.92649625 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91962779 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91519474 |
| 92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.89774198 |
| 93 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.89442283 |
| 94 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.88931321 |
| 95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.88855476 |
| 96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88107970 |
| 97 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87927717 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87271279 |
| 99 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.84888573 |
| 100 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.84792591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.88243125 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.67921706 |
| 3 | MP0000685_abnormal_immune_system | 2.64519467 |
| 4 | MP0002102_abnormal_ear_morphology | 2.52286412 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34935119 |
| 6 | MP0005671_abnormal_response_to | 2.31131556 |
| 7 | MP0000372_irregular_coat_pigmentation | 2.30571377 |
| 8 | MP0004043_abnormal_pH_regulation | 2.20662027 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.13440598 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.05648051 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.03472578 |
| 12 | MP0003283_abnormal_digestive_organ | 2.03218677 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.03064481 |
| 14 | MP0003195_calcinosis | 1.98495946 |
| 15 | MP0004885_abnormal_endolymph | 1.92599494 |
| 16 | MP0000604_amyloidosis | 1.88930100 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 1.88112282 |
| 18 | MP0005084_abnormal_gallbladder_morpholo | 1.82813893 |
| 19 | MP0006292_abnormal_olfactory_placode | 1.82019686 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.75666532 |
| 21 | MP0002163_abnormal_gland_morphology | 1.63033495 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 1.62170294 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.61455252 |
| 24 | MP0003787_abnormal_imprinting | 1.59853777 |
| 25 | MP0005387_immune_system_phenotype | 1.59021922 |
| 26 | MP0001790_abnormal_immune_system | 1.59021922 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.57987793 |
| 28 | MP0009379_abnormal_foot_pigmentation | 1.57201162 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.52750898 |
| 30 | MP0004142_abnormal_muscle_tone | 1.51439749 |
| 31 | MP0001800_abnormal_humoral_immune | 1.50556051 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.48287333 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.45597587 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.44452767 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.42517999 |
| 36 | MP0001984_abnormal_olfaction | 1.42489033 |
| 37 | MP0005083_abnormal_biliary_tract | 1.39722047 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.38212933 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.35044368 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.32038831 |
| 41 | MP0004147_increased_porphyrin_level | 1.31967002 |
| 42 | MP0003718_maternal_effect | 1.31409459 |
| 43 | MP0000538_abnormal_urinary_bladder | 1.27588605 |
| 44 | MP0003011_delayed_dark_adaptation | 1.26953561 |
| 45 | MP0002006_tumorigenesis | 1.26716319 |
| 46 | MP0002405_respiratory_system_inflammati | 1.25729756 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.22905478 |
| 48 | MP0002234_abnormal_pharynx_morphology | 1.22834620 |
| 49 | MP0001853_heart_inflammation | 1.20363304 |
| 50 | MP0002723_abnormal_immune_serum | 1.20102539 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.19668216 |
| 52 | MP0003786_premature_aging | 1.17791942 |
| 53 | MP0003252_abnormal_bile_duct | 1.16104081 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.11542878 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.10651621 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.07928205 |
| 57 | MP0003329_amyloid_beta_deposits | 1.07889370 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.07865155 |
| 59 | MP0005253_abnormal_eye_physiology | 1.05444369 |
| 60 | MP0008872_abnormal_physiological_respon | 1.04083766 |
| 61 | MP0003646_muscle_fatigue | 1.02940108 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.01190087 |
| 63 | MP0002938_white_spotting | 1.00377965 |
| 64 | MP0002452_abnormal_antigen_presenting | 0.99809258 |
| 65 | MP0001756_abnormal_urination | 0.99477962 |
| 66 | MP0002420_abnormal_adaptive_immunity | 0.99457954 |
| 67 | MP0010155_abnormal_intestine_physiology | 0.99239909 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 0.98579546 |
| 69 | MP0001819_abnormal_immune_cell | 0.97578044 |
| 70 | MP0003866_abnormal_defecation | 0.96895999 |
| 71 | MP0006082_CNS_inflammation | 0.96620460 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 0.95129824 |
| 73 | MP0005389_reproductive_system_phenotype | 0.94916740 |
| 74 | MP0002272_abnormal_nervous_system | 0.93338885 |
| 75 | MP0001905_abnormal_dopamine_level | 0.90407380 |
| 76 | MP0004742_abnormal_vestibular_system | 0.89719792 |
| 77 | MP0001873_stomach_inflammation | 0.89522730 |
| 78 | MP0009745_abnormal_behavioral_response | 0.88948211 |
| 79 | MP0005025_abnormal_response_to | 0.88275490 |
| 80 | MP0002160_abnormal_reproductive_system | 0.88101444 |
| 81 | MP0009785_altered_susceptibility_to | 0.87086070 |
| 82 | MP0004381_abnormal_hair_follicle | 0.86283854 |
| 83 | MP0002736_abnormal_nociception_after | 0.85902879 |
| 84 | MP0009046_muscle_twitch | 0.85211237 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.84991164 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.84256453 |
| 87 | MP0003878_abnormal_ear_physiology | 0.84183030 |
| 88 | MP0005377_hearing/vestibular/ear_phenot | 0.84183030 |
| 89 | MP0003724_increased_susceptibility_to | 0.83925913 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.83316639 |
| 91 | MP0005332_abnormal_amino_acid | 0.82131185 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.81953789 |
| 93 | MP0001970_abnormal_pain_threshold | 0.81850750 |
| 94 | MP0001661_extended_life_span | 0.81470885 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.81150731 |
| 96 | MP0002733_abnormal_thermal_nociception | 0.78132372 |
| 97 | MP0009764_decreased_sensitivity_to | 0.76528318 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.75092674 |
| 99 | MP0002398_abnormal_bone_marrow | 0.74224235 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.74078716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.10193988 |
| 2 | 3-Methylglutaconic aciduria (HP:0003535) | 4.44405424 |
| 3 | Generalized aminoaciduria (HP:0002909) | 4.41875594 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.32287198 |
| 5 | Congenital, generalized hypertrichosis (HP:0004540) | 3.72769549 |
| 6 | IgG deficiency (HP:0004315) | 3.69998075 |
| 7 | Increased IgM level (HP:0003496) | 3.69949841 |
| 8 | Abnormality of the renal cortex (HP:0011035) | 3.30757834 |
| 9 | Renal cortical cysts (HP:0000803) | 3.21949305 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.18731371 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.13047464 |
| 12 | Hepatic necrosis (HP:0002605) | 3.12835797 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.09131560 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.08003477 |
| 15 | Pancreatic cysts (HP:0001737) | 3.07023224 |
| 16 | Nephronophthisis (HP:0000090) | 3.04805931 |
| 17 | Reduced antithrombin III activity (HP:0001976) | 3.04225240 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 3.02132970 |
| 19 | Increased CSF lactate (HP:0002490) | 2.99782474 |
| 20 | Abnormality of alanine metabolism (HP:0010916) | 2.98235303 |
| 21 | Hyperalaninemia (HP:0003348) | 2.98235303 |
| 22 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.98235303 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97362853 |
| 24 | Severe combined immunodeficiency (HP:0004430) | 2.85449932 |
| 25 | Thyroiditis (HP:0100646) | 2.81158899 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.79934712 |
| 27 | Medial flaring of the eyebrow (HP:0010747) | 2.79884732 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73984453 |
| 29 | Acute encephalopathy (HP:0006846) | 2.70309109 |
| 30 | Abnormality of the renal medulla (HP:0100957) | 2.69626915 |
| 31 | Tongue fasciculations (HP:0001308) | 2.67631074 |
| 32 | Progressive macrocephaly (HP:0004481) | 2.66067719 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.62774562 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 2.60325327 |
| 35 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.57677786 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.57530968 |
| 37 | Glycosuria (HP:0003076) | 2.55932162 |
| 38 | Abnormality of urine glucose concentration (HP:0011016) | 2.55932162 |
| 39 | Large eyes (HP:0001090) | 2.48673483 |
| 40 | Renal Fanconi syndrome (HP:0001994) | 2.48354697 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.48244183 |
| 42 | Type 2 muscle fiber atrophy (HP:0003554) | 2.47050359 |
| 43 | Mesangial abnormality (HP:0001966) | 2.46906110 |
| 44 | Pancreatic fibrosis (HP:0100732) | 2.45928142 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.45089786 |
| 46 | Optic disc pallor (HP:0000543) | 2.41339892 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.38206653 |
| 48 | Abolished electroretinogram (ERG) (HP:0000550) | 2.32974252 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.32176648 |
| 50 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.30588989 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.27044971 |
| 52 | True hermaphroditism (HP:0010459) | 2.27038121 |
| 53 | Chronic hepatic failure (HP:0100626) | 2.25642654 |
| 54 | Exertional dyspnea (HP:0002875) | 2.23093720 |
| 55 | Muscle fibrillation (HP:0010546) | 2.22598726 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.22512753 |
| 57 | Abnormality of T cells (HP:0002843) | 2.19252823 |
| 58 | Eosinophilia (HP:0001880) | 2.17954929 |
| 59 | Gait imbalance (HP:0002141) | 2.17083866 |
| 60 | Hypoproteinemia (HP:0003075) | 2.15137625 |
| 61 | Hypothermia (HP:0002045) | 2.14985717 |
| 62 | Limb dystonia (HP:0002451) | 2.13958899 |
| 63 | Constricted visual fields (HP:0001133) | 2.13124525 |
| 64 | Lactic acidosis (HP:0003128) | 2.08337399 |
| 65 | Joint swelling (HP:0001386) | 2.06171031 |
| 66 | Menstrual irregularities (HP:0000858) | 2.05704485 |
| 67 | Increased serum lactate (HP:0002151) | 2.04343718 |
| 68 | Pendular nystagmus (HP:0012043) | 2.03981750 |
| 69 | Muscle fiber atrophy (HP:0100295) | 2.00860216 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96005110 |
| 71 | Abnormality of the labia minora (HP:0012880) | 1.95140257 |
| 72 | Severe muscular hypotonia (HP:0006829) | 1.93447873 |
| 73 | Combined immunodeficiency (HP:0005387) | 1.93207770 |
| 74 | Pachygyria (HP:0001302) | 1.90414188 |
| 75 | Tubular atrophy (HP:0000092) | 1.87595222 |
| 76 | Abnormality of T cell number (HP:0011839) | 1.86281264 |
| 77 | IgA deficiency (HP:0002720) | 1.85443101 |
| 78 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.84571648 |
| 79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.84571648 |
| 80 | Polyuria (HP:0000103) | 1.84154635 |
| 81 | B lymphocytopenia (HP:0010976) | 1.84097954 |
| 82 | Cerebral edema (HP:0002181) | 1.84084773 |
| 83 | Congenital primary aphakia (HP:0007707) | 1.83801460 |
| 84 | Abnormal drinking behavior (HP:0030082) | 1.83745108 |
| 85 | Polydipsia (HP:0001959) | 1.83745108 |
| 86 | Abnormality of the pons (HP:0007361) | 1.81210033 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 1.80856569 |
| 88 | Abnormality of midbrain morphology (HP:0002418) | 1.80856569 |
| 89 | Increased muscle lipid content (HP:0009058) | 1.78982943 |
| 90 | Testicular atrophy (HP:0000029) | 1.76655991 |
| 91 | Lethargy (HP:0001254) | 1.74571228 |
| 92 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73458133 |
| 93 | Hypoplasia of the pons (HP:0012110) | 1.73039392 |
| 94 | Decreased central vision (HP:0007663) | 1.72678858 |
| 95 | Cerebral palsy (HP:0100021) | 1.72566995 |
| 96 | Abnormal protein glycosylation (HP:0012346) | 1.72562095 |
| 97 | Abnormal glycosylation (HP:0012345) | 1.72562095 |
| 98 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.72562095 |
| 99 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.72562095 |
| 100 | Decreased circulating renin level (HP:0003351) | 1.72461140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.74563605 |
| 2 | VRK2 | 4.23920427 |
| 3 | NME2 | 3.76547875 |
| 4 | BMPR1B | 3.28108015 |
| 5 | TLK1 | 2.36203207 |
| 6 | TAF1 | 2.27155929 |
| 7 | FRK | 2.20748701 |
| 8 | ADRBK2 | 2.14196353 |
| 9 | TXK | 2.12366984 |
| 10 | ZAK | 2.11151298 |
| 11 | KIT | 1.94064895 |
| 12 | INSRR | 1.91821496 |
| 13 | WNK3 | 1.91521339 |
| 14 | VRK1 | 1.86075716 |
| 15 | FLT3 | 1.84604604 |
| 16 | BCKDK | 1.83772894 |
| 17 | CAMKK2 | 1.79066116 |
| 18 | MKNK1 | 1.61763427 |
| 19 | GRK1 | 1.60890184 |
| 20 | PASK | 1.57180459 |
| 21 | MAP4K2 | 1.51411751 |
| 22 | ACVR1B | 1.50104632 |
| 23 | PHKG2 | 1.39677307 |
| 24 | PHKG1 | 1.39677307 |
| 25 | DYRK2 | 1.33077134 |
| 26 | TIE1 | 1.32008315 |
| 27 | PKN2 | 1.30657756 |
| 28 | WNK4 | 1.30458267 |
| 29 | IKBKB | 1.25994489 |
| 30 | MAP4K1 | 1.22821917 |
| 31 | CDK8 | 1.22648082 |
| 32 | PINK1 | 1.20654086 |
| 33 | TGFBR1 | 1.17730642 |
| 34 | KDR | 1.16087403 |
| 35 | IKBKE | 1.15545277 |
| 36 | MAPKAPK5 | 1.13740058 |
| 37 | GRK6 | 1.13476895 |
| 38 | SYK | 1.11034413 |
| 39 | MARK1 | 1.10840752 |
| 40 | NUAK1 | 1.07486849 |
| 41 | TNK2 | 0.98186909 |
| 42 | MAPK13 | 0.96842873 |
| 43 | DAPK2 | 0.96725821 |
| 44 | TEC | 0.94440312 |
| 45 | FES | 0.93012619 |
| 46 | MAP3K4 | 0.92601305 |
| 47 | NME1 | 0.92132812 |
| 48 | LYN | 0.91162652 |
| 49 | MKNK2 | 0.89279641 |
| 50 | MAP2K6 | 0.85101576 |
| 51 | RPS6KA5 | 0.82340897 |
| 52 | ITK | 0.80475904 |
| 53 | BTK | 0.78964589 |
| 54 | MAP3K14 | 0.77518052 |
| 55 | RPS6KA4 | 0.77313661 |
| 56 | STK16 | 0.74483947 |
| 57 | ADRBK1 | 0.72023912 |
| 58 | CAMKK1 | 0.70307414 |
| 59 | TSSK6 | 0.65857743 |
| 60 | CHUK | 0.65097627 |
| 61 | CSK | 0.63339265 |
| 62 | PRKCQ | 0.63176085 |
| 63 | BCR | 0.62953136 |
| 64 | AKT3 | 0.61163050 |
| 65 | CSNK1G2 | 0.57116639 |
| 66 | MATK | 0.56818447 |
| 67 | CSNK1G3 | 0.55085848 |
| 68 | CDK9 | 0.55022470 |
| 69 | MELK | 0.54143104 |
| 70 | TGFBR2 | 0.54142261 |
| 71 | PRKCE | 0.53422733 |
| 72 | CSNK1A1L | 0.51880001 |
| 73 | LCK | 0.50033908 |
| 74 | ABL2 | 0.47341620 |
| 75 | CDC7 | 0.46626784 |
| 76 | BLK | 0.45970146 |
| 77 | EIF2AK2 | 0.45396536 |
| 78 | MAP2K7 | 0.44459515 |
| 79 | NTRK3 | 0.40638648 |
| 80 | DYRK1A | 0.40491342 |
| 81 | MST4 | 0.38310602 |
| 82 | PRKD3 | 0.38017518 |
| 83 | PIM1 | 0.37917235 |
| 84 | PAK3 | 0.37844654 |
| 85 | NTRK2 | 0.36200758 |
| 86 | BMPR2 | 0.36159149 |
| 87 | OXSR1 | 0.35872116 |
| 88 | MAP3K7 | 0.35630668 |
| 89 | MARK3 | 0.35332080 |
| 90 | CASK | 0.34797515 |
| 91 | OBSCN | 0.30585875 |
| 92 | PRKACA | 0.30474405 |
| 93 | STK38L | 0.30436277 |
| 94 | CSNK1A1 | 0.29987548 |
| 95 | PRKCG | 0.29830699 |
| 96 | FGFR1 | 0.28926932 |
| 97 | PRKG1 | 0.28215674 |
| 98 | EPHA3 | 0.28165931 |
| 99 | PRKCD | 0.28016236 |
| 100 | PRKCA | 0.27867330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.54134044 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.35853336 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.29413379 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.26134562 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.17158229 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.88748406 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.80921767 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.80470539 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.75101762 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.58757564 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.40482982 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26829147 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.22561792 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.85618504 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83557668 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.83214047 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.82598171 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.78305324 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76655073 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70431065 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64588684 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.64377226 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64219408 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.56847421 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52072012 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.51172951 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31278389 |
| 28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.31190984 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.28654399 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25290017 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22092007 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21797660 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18419398 |
| 34 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.15691435 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.14819222 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08634580 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03943913 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01242051 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00735988 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00238229 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96472187 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92937190 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88864072 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85372718 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84547149 |
| 46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84075265 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80441153 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80153231 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78896050 |
| 50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78871617 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78144838 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74774988 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74118860 |
| 54 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71810878 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71185700 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65709997 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64399680 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63861274 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62932906 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.62214434 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61994875 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59680863 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.59241484 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59121283 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.57098937 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57072756 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.55584081 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54114135 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51886069 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51726661 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51442474 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.50364007 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49247687 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48137130 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.46017348 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45238373 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.44742218 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42802124 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42597663 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41570448 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41371575 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40618104 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36782205 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36703583 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36539300 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36025523 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.35222826 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.34394617 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34360267 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.34117982 |
| 91 | RNA transport_Homo sapiens_hsa03013 | 0.31665420 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30659382 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.30169348 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29028847 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.27800103 |
| 96 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.24960670 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24811014 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23182098 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21842881 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.21762191 |

